Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02433626
Title Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Malignancies (COTI2-101)
Acronym COTI2-101
Recruitment Unknown status
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Critical Outcome Technologies Inc.
Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST